LOINC
Version 2.66

83082-8Cancer Ag 125 [Units/volume] in Serum or Plasma by ImmunoassayActive

Component
Cancer Ag 125
Property
ACnc
Time
Pt
System
Ser/Plas
Scale
Qn
Method
IA

Additional Names

Short Name
Cancer Ag125 SerPl IA-aCnc
Display Name Beta
Cancer Ag 125 IA Qn
Consumer Name Alpha
Cancer Ag 125, Blood

Term Description

This term was created for, but is not limited in use to, bioMerieux's VIDAS CA 125 II assay, which is intended for the quantitative measurement of the OC
125 antigenic determinants in human serum or plasma.
Source: Regenstrief LOINC

Part Description

LP14543-0   Cancer Ag 125
CA 125 is an antigenic determinant associated with a mucin-like glycoprotein, molecular weight exceeding 500,000 Daltons. This determinant is recognized by the murine monoclonal antibody OC 125, which reacts with over 80% of epithelial ovarian cancers. Elevated CA 125 levels have been reported in subjects with serous, endometrioid, clear cell, and undifferentiated ovarian carcinoma adenocarcinoma of the endometrium or fallopian tube, as well as some nongynocologic malignancies and certain nonmalignant conditions. Elevated levels also have been observed in pregnant women, most often during the first trimester. CA 125 levels may have significant value in monitoring ovarian carcinoma patients. A persistently rising CA 125 value may be associated with progressive malignant disease and poor therapeutic response. A declining CA 125 value is indicative of favorable prognosis and good response to treatment. CA 125 levels may help predict whether an invasive second-look procedure such as laparoscopy or laparotomy is required after treatment for epithelial ovarian cancer.
I.A. KOELMA, M. NAP, C.J. RODENBURG, G.J. FLEUREN (1987) The value of tumour marker CA 125 in surgical pathology
Histopathology 11 (3) , 287–294 doi:10.1111/j.1365-2559.1987.tb02633. Source: Regenstrief Institute

Basic Attributes

Class
CHEM
Type
Laboratory
First Released
Version 2.58
Last Updated
Version 2.58
Order vs. Observation
Both

Member of these Groups

LG108-7 Cancer Ag 125|ACnc|Pt|ANYBldSerPl

Language Variants Get Info

zh-CNChinese (China)
癌抗原 125:任意型浓度:时间点:血清/血浆:定量型:免疫测定法
nl-NLDutch (Netherlands)
CA125:eenheid/volume:moment:serum of plasma:kwantitatief:immunoassay
et-EEEstonian (Estonia)
Kasvajaantigeen CA 125:Acnc:Pt:S/P:Qn:IA
fr-BEFrench (Belgium)
Ag carbohydraté 125:Concentration arbitraire:Temps ponctuel:Sérum/Plasma:Quantitatif:IA
fr-CAFrench (Canada)
Ag carbohydraté 125:Concentration arbitraire:Temps ponctuel:Sérum/Plasma:Quantitatif:IA
fr-FRFrench (France)
Cancer Ag 125:ACnc:Pt:Ser/Plas:Qn:IA
el-GRGreek (Greece)
Καρκινικό αντιγόνο 125:Αυθαίρετη συγκέντρωση:Χρονική στιγμή:Ορός/Πλάσμα:Ποσοτική:IA
it-ITItalian (Italy)
Cancro, Ag 125:ACnc:Pt:Siero/Plasma:Qn:IA
ru-RURussian (Russian Federation)
Раковый Аг 125:ПроизвКонц:ТчкВрм:Сыв/Плаз:Колич:IA
es-ESSpanish (Spain)
Ag de cáncer 125:Concentración arbitraria:Punto temporal:Suero o Plasma:Qn:IA
tr-TRTurkish (Turkey)
Kanser Ag 125:SçKons:Zmlı:Ser/Plaz:Kant:İA

Example Units

Unit Source
U/mL Example UCUM Units

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=83082-8